95 related articles for article (PubMed ID: 20597080)
1. Pilot study: The effect of reducing treatment on exercise induced bronchoconstriction.
Kersten ET; Driessen JM; van Leeuwen JC; Thio BJ
Pediatr Pulmonol; 2010 Sep; 45(9):927-33. PubMed ID: 20597080
[TBL] [Abstract][Full Text] [Related]
2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
3. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
4. Managing symptoms and exacerbations in pediatric asthma.
Verberne AA
Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102
[TBL] [Abstract][Full Text] [Related]
5. How do children and their caregivers perceive the benefits of inhaled asthma therapy?
Gilchrist FJ; Brady M; Gallop K; Wild DJ; Tabberer M; Jacques L; Lenney W
J Asthma; 2012 Jun; 49(5):552-6. PubMed ID: 22486488
[TBL] [Abstract][Full Text] [Related]
6. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
7. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
Perrin K; Williams M; Wijesinghe M; James K; Weatherall M; Beasley R
J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
10. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
Hoffmann HJ; Nielsen LP; Harving H; Heinig JH; Dahl R
Clin Respir J; 2008 Jul; 2(3):149-57. PubMed ID: 20298323
[TBL] [Abstract][Full Text] [Related]
11. The effect of stepping down combination therapy on airway hyperresponsiveness to mannitol.
Kersten ET; Driessen JM; Duiverman EJ; Thio BJ
Respir Med; 2011 May; 105(5):691-7. PubMed ID: 21129943
[TBL] [Abstract][Full Text] [Related]
12. The β-2 agonist debate: is there still a problem?
Patel M; Shirtcliffe P; Beasley R
Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):58-62. PubMed ID: 23037719
[TBL] [Abstract][Full Text] [Related]
13. Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study.
Turner SW; Richardson K; Burden A; Thomas M; Murray C; Price D
NPJ Prim Care Respir Med; 2015 Jun; 25():15041. PubMed ID: 26068328
[TBL] [Abstract][Full Text] [Related]
14. The prevention of exercise-induced bronchoconstriction: what are the options?
Anderson SD
Expert Rev Respir Med; 2012 Aug; 6(4):355-7. PubMed ID: 22971059
[No Abstract] [Full Text] [Related]
15. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
Gibson PG; Powell H; Ducharme FM
J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
[TBL] [Abstract][Full Text] [Related]
16. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
Gillissen A; Gessner C; Hoheisel G; Juergens U
Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy.
Kanazawa H; Tochino Y; Asai K
J Allergy Clin Immunol; 2008 Feb; 121(2):390-5. PubMed ID: 18037159
[TBL] [Abstract][Full Text] [Related]
18. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study.
Thomas M; von Ziegenweidt J; Lee AJ; Price D
J Allergy Clin Immunol; 2009 Jan; 123(1):116-121.e10. PubMed ID: 18986690
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
Kiri VA; Fabbri LM; Davis KJ; Soriano JB
Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for the management of exercise-induced asthma and bronchoconstriction.
Millward DT; Tanner LG; Brown MA
Phys Sportsmed; 2010 Dec; 38(4):74-80. PubMed ID: 21150145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
